Clinical Trials
Braintumor Website

There are 18 trials:
Facility: MD Anderson Cancer Center
NCT Trial Name# of Centers

NCT02523014

  A Study Looking at Targeted Therapy According to Tumor Markers for People With Meningiomas
340

NCT02796261

  Study to Evaluate Eflornithine + Lomustine vs Lomustine in Recurrent Anaplastic Astrocytoma (AA) Patients
77

NCT02320058

  An Investigational Immuno-therapy Study to Evaluate Safety and Effectiveness in Patients With Melanoma That Has Spread to the Brain, Treated With Nivolumab in Combination With Ipilimumab, Followed by Nivolumab by Itself
35

NCT02709889

  Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors
28

NCT02639546

  iMATRIXcobi: Safety and Pharmacokinetics of Cobimetinib in Pediatric and Young Adult Patients With Previously Treated Solid Tumors
24

NCT02048059

  ANG1005 in Breast Cancer Patients With Recurrent Brain Metastases
17

NCT02798406

  Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
12

NCT01494662

  HKI-272 for HER2-Positive Breast Cancer and Brain Metastases
11

NCT02658279

  Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype
9

NCT02576665

  A Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC in Patients With Solid Tumors or Lymphoma (Toca 6)
3

NCT01295944

  Carboplatin and Bevacizumab for Recurrent Ependymoma
3

NCT01063114

  Proton Beam Radiotherapy for Medulloblastoma and Pineoblastoma
2

NCT02340156

  Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
2

NCT02693990

  A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas
2

NCT03215511

  Phase 1/2 Study of LOXO-195 in Patients With Previously Treated NTRK Fusions or Non-fusion NTRK Cancers
2

NCT02626364

  Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification
1

NCT02254954

  Macitentan, RT and TMZ Concurrent Therapy Followed by Maintenance Macitentan and TMZ in Newly Diagnosed GBM.
1

NCT01499251

  Macitentan in Combo With Dose-dense Temozolomide in Patients With Recurrent Glioblastoma
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites